Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Autor: Miklos Pless, R. Stahel, Anastase Spiliopoulos, Markus Furrer, Arnaud Roth, C. Von Briel, James Habicht, M. Wernli, Eva Hansen, Ralph A. Schmid, Martin Tötsch, Christine Joss, Fritz Egli, Hanspeter Honegger, H-B Ris, Thomas Cerny, Daniel C. Betticher, W. Weder, S-F Hsu Schmitz, Roger Stupp

Publikováno v: British journal of cancer, vol. 94, no. 8, pp. 1099-106
British Journal of Cancer, Vol. 94, No 8 (2006) pp. 1099-106
British Journal of Cancer

The aim was to investigate the efficacy of neoadjuvant docetaxel–cisplatin and identify prognostic factors for outcome in locally advanced stage IIIA (pN2 by mediastinoscopy) non-small-cell lung cancer (NSCLC) patients. In all, 75 patients (from 90

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3dc1cf64797ae33965e63698aaee81f
https://doi.org/10.1038/sj.bjc.6603075